Abag, Sahla .
HRN: 26-81-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/29/2025
CEFUROXIME 500MG (TAB)
03/29/2025
04/05/2025
ORAL
500 Mg/tab
Bid
S/p Nsd With 3rd Degree Laceration
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes